Aidoc Secures $150 Million Series E to Scale Clinical AI Platform and Foundation Model

New updates have been reported about Aidoc.

Aidoc has raised $150 million in a Series E round led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors and NVentures, bringing its total funding to more than $500 million and reinforcing investor conviction in enterprise-scale clinical AI. The company plans to use the capital to accelerate development and deployment of its CARE clinical foundation model and aiOS enterprise AI platform, positioning itself to capture growing demand from health systems seeking unified, regulated AI infrastructure.

Aidoc’s CARE model recently received a first-of-its-kind FDA clearance for a comprehensive, multi-condition triage system in clinical imaging, enabling broader coverage across CT and X-ray and supporting an ambition to progress from pixels to draft radiology reports within two years. With its technology already reviewing over 60 million patient cases annually across nearly 2,000 hospitals, Aidoc aims to expand into additional clinical indications, enhance automation of imaging workflows and scale global deployments, while emphasizing governance, regulatory rigor and measurable financial returns for health systems adopting its platform.